<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">oncotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский онкологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian journal of oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-4861</issn><issn pub-type="epub">2312-3168</issn><publisher><publisher-name>Tomsk National Research Medical Сепtеr of the Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21294/1814-4861-2022-21-1-130-136</article-id><article-id custom-type="elpub" pub-id-type="custom">oncotomsk-2037</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Применение биосовместимых композитных структур (скаффолдов) в онкологии</article-title><trans-title-group xml:lang="en"><trans-title>The use of biocompatible composite scaffolds in oncology</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3061-6108</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кит</surname><given-names>О. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kit</surname><given-names>O. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кит Олег Иванович, член-корреспондент РАН, профессор, генеральный директор</p><p>SPIN-код: 1728-0329</p><p>Россия, 344037, г. Ростов-на-Дону, 14-я линия, 63</p></bio><bio xml:lang="en"><p>Oleg I. Kit, MD, DSc, Professor, Corresponding Member of the Academy of Medical Sciences, General Director</p><p>SPIN-code: 1728-0329</p><p>63, 14th Line St., 344037, Rostov-on-Don, Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максимов</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Maksimov</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Максимов Алексей Юрьевич, доктор медицинских наук, профессор, заместитель генерального директора по перспективным научным разработкам</p><p>SPIN-код: 7322-5589. Author ID (Scopus): 56579049500</p><p>Россия, 344037, г. Ростов-на-Дону, 14-я линия, 63</p></bio><bio xml:lang="en"><p>Aleksey Yu. Maksimov, MD, DSc, Professor, Deputy Director</p><p>SPIN-code: 7322-5589. Author ID (Scopus): 56579049500</p><p>63, 14th Line St., 344037, Rostov-on-Don, Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6496-9641</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новикова Инна Арнольдовна, кандидат медицинских наук, заместитель генерального директора по науке</p><p>SPIN-код: 4810-2424. Researcher ID (WOS): E-7710-2018. Author ID (Scopus): 57202252773</p><p>Россия, 344037, г. Ростов-на-Дону, 14-я линия, 63</p></bio><bio xml:lang="en"><p>Inna A. Novikova, MD, PhD, Deputy Director for Science</p><p>SPIN-code: 4810-2424. Researcher ID (WOS): E-7710-2018. Author ID (Scopus): 57202252773</p><p>63, 14th Line St., 344037, Rostov-on-Don, Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0676-0871</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гончарова</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Goncharova</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гончарова Анна Сергеевна, кандидат биологических наук, заведующая отделением «Испытательный лабораторный центр»</p><p>SPIN-код: 7512-2039</p><p>Россия, 344037, г. Ростов-на-Дону, 14-я линия, 63</p></bio><bio xml:lang="en"><p>Anna S. Goncharova, PhD, Head of Testing Laboratory Center</p><p>SPIN-code: 7512-2039</p><p>63, 14th Line St., 344037, Rostov-on-Don, Russia</p></bio><email xlink:type="simple">fateyeva_a_s@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3036-6199</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукбанова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukbanova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лукбанова Екатерина Алексеевна, научный сотрудник</p><p>SPIN-код: 4078-4200</p><p>Россия, 344037, г. Ростов-на-Дону, 14-я линия, 63</p></bio><bio xml:lang="en"><p>Ekaterina A. Lukbanova, Researcher</p><p>SPIN-code: 4078-4200</p><p>63, 14th Line St., 344037, Rostov-on-Don, Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6035-1756</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ситковская</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Sitkovskaya</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ситковская Анастасия Олеговна, заведующая отделением «Лаборатория клеточных технологий»</p><p>SPIN-код: 1659-6976. Researcher ID (WOS): E-7496-2018. Author ID (Scopus): 56381527400</p><p>Россия, 344037, г. Ростов-на-Дону, 14-я линия, 63</p></bio><bio xml:lang="en"><p>Anastasiya O. Sitkovskaya, Head of Cell Technology Laboratory</p><p>SPIN-code: 1659-6976. Researcher ID (WOS): E-7496-2018. Author ID (Scopus): 56381527400</p><p>63, 14th Line St., 344037, Rostov-on-Don, Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0120-7244</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воловик</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Volovik</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воловик Вячеслав Георгиевич, аспирант</p><p>Россия, 344037, г. Ростов-на-Дону, 14-я линия, 63</p></bio><bio xml:lang="en"><p>Vyacheslav G. Volovik, Postgraduate</p><p>63, 14th Line St., 344037, Rostov-on-Don, Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8172-8666</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чапек</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chapek</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чапек Сергей Валентинович, эксперт научно-сследовательской лаборатории «Инженерные технологии в медицине»</p><p>SPIN-код: 6689-3406</p><p>Россия, 344002, г. Ростов-на-Дону, пл. Гагарина, 1</p></bio><bio xml:lang="en"><p>Sergey V. Chapek, Expert of the Laboratory of Engineering Technologies in Medicine</p><p>SPIN-code: 6689-3406</p><p>1, Gagarin Sq., 344001, Rostov-on-Don, Russia</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Institute of Oncology, the Ministry of Health of the Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Донской государственный технический университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Don State Technical University, the Ministry of Health of the Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>03</day><month>03</month><year>2022</year></pub-date><volume>21</volume><issue>1</issue><fpage>130</fpage><lpage>136</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кит О.И., Максимов А.Ю., Новикова И.А., Гончарова А.С., Лукбанова Е.А., Ситковская А.О., Воловик В.Г., Чапек С.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Кит О.И., Максимов А.Ю., Новикова И.А., Гончарова А.С., Лукбанова Е.А., Ситковская А.О., Воловик В.Г., Чапек С.В.</copyright-holder><copyright-holder xml:lang="en">Kit O.I., Maksimov A.Y., Novikova I.A., Goncharova A.S., Lukbanova E.A., Sitkovskaya A.O., Volovik V.G., Chapek S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.siboncoj.ru/jour/article/view/2037">https://www.siboncoj.ru/jour/article/view/2037</self-uri><abstract><p>Современные подходы тканевой инженерии направлены на разработку конструкций (скаффолдов), способствующих развитию всего разнообразия межклеточных взаимодействий, имитирующих таковые в реальном объекте.</p><p>Цель исследования заключалась в сборе и обобщении данных по созданию и использованию трехмерных клеточных матриц.</p><sec><title>Материал и методы</title><p>Материал и методы. Выполнен поиск тематических статей с использованием ключевых слов как в международных базах данных PubMed и Medline, так и в отечественных – Cyber Leninka и Elibrary. В результате литературного поиска нами было отобрано 315 статей по изучаемой тематике, далее по результатам детального анализа текстов было взято 37 публикаций, результаты которых послужили предметом обсуждения данного обзора.</p></sec><sec><title>Результаты</title><p>Результаты. Проведен обзор исследований, посвященных разработке трехмерных композитных структур (скаффолдов) и их применению в области клеточных технологий. Рассмотрены способы изготовления биосовместимых конструкций с использованием как естественных биоматериалов, так и синтетических, в том числе различных гидрогелей и титановых сплавов, а также обсуждаются их некоторые физические и химические характеристики. В обзоре обсуждаются возможные варианты применения трехмерных композитных структур в онкологии в качестве одного из возможных инструментов для расширения фундаментальных представлений о закономерностях развития злокачественного процесса, а также и для использования в работах по разработке эффективных методов лечения и поиску новых лекарственных средств. Обозначены перспективы применения скаффолдов в области экспериментальной онкологии, а именно в создании различного рода опухолевых моделей. Освещено применение специализированных клеточных матриц с целью реконструкции поврежденных тканей.</p></sec><sec><title>Заключение</title><p>Заключение. В настоящее время трехмерные культуральные системы приходят на смену двухмерным моделям. Успехи в этом направлении связаны с созданием и разработкой различных вариантов клеточных матриц, способствующих решению ряда прикладных задач в области создания трехмерных опухолевых моделей in vitro и in vivo, терапии злокачественных опухолей и восстановительной медицины.</p></sec></abstract><trans-abstract xml:lang="en"><p>Modern tissue engineering approaches are aimed at developing scaffolds that contribute to the development of the whole variety of intercellular interactions that imitate those in a real object.</p><p>The purpose of the study was to collect and summarize the data on the creation and use of three-dimensional cellular matrices.</p><sec><title>Material and Methods</title><p>Material and Methods. A systematic literature search was conducted in the PubMed, Medline, Cyber Leninka and Elibrary databases. Out of the 315 articles searched, 38 were selected for this review.</p></sec><sec><title>Results</title><p>Results. A review of studies devoted to the development of three-dimensional composite structures (scaffolds) and their application in the field of cellular technologies was carried out. Methods for the manufacture of biocompatible structures using both natural biomaterials and synthetic ones, including various hydrogels and titanium alloys, were considered, and some physical and chemical characteristics were also discussed. The review discussed possible applications of 3D composite structures in oncology as one of the possible tools for expanding the fundamental understanding of the patterns of development of the malignant process, but also for use in the development of effective methods of treatment and the search for new drugs. The prospects for the use of scaffolds in the field of experimental oncology, namely in the creation of various types of tumor models, were outlined.</p></sec><sec><title>Conclusion</title><p>Conclusion. Currently, three-dimensional culture systems are replacing two-dimensional models. Advances in this direction are associated with the creation and development of various variants of cell matrices that contribute to the solution of a number of applied problems in the field of creating three-dimensional tumor models in vitro and in vivo, therapy of malignant tumors and restorative medicine.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>скаффолд</kwd><kwd>клеточные матрицы</kwd><kwd>3D-моделирование</kwd><kwd>опухолевые модели</kwd></kwd-group><kwd-group xml:lang="en"><kwd>scaffold</kwd><kwd>cellular matrices</kwd><kwd>3D modeling</kwd><kwd>tumor models</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fong E.L., Harrington D.A., Farach-Carson M.C., Yu H. Heralding a new paradigm in 3D tumor modeling. Biomaterials. 2016 Nov; 108: 197–213. doi: 10.1016/j.biomaterials.2016.08.052.</mixed-citation><mixed-citation xml:lang="en">Fong E.L., Harrington D.A., Farach-Carson M.C., Yu H. Heralding a new paradigm in 3D tumor modeling. Biomaterials. 2016 Nov; 108: 197–213. doi: 10.1016/j.biomaterials.2016.08.052.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Садовой М.А., Ларионов П.М., Самохин А.Г., Рожнова О.М. Клеточные матрицы (скаффолды) для целей регенерации кости: современное состояние проблемы. Хирургия позвоночника. 2014; (2): 79–86.</mixed-citation><mixed-citation xml:lang="en">Sadovoy M.A., Larionov P.M., Samokhin A.G., Rozhnova O.M. Cellular matrices (scaffolds) for bone regeneration: the current state of the problem. Spine Surgery. 2014; (2): 79–86. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hutmacher D.W. Biomaterials offer cancer research the third dimension. Nature materials. 2010 Feb; 9(2): 90–3. doi:10.1038/nmat2619.</mixed-citation><mixed-citation xml:lang="en">Hutmacher D.W. Biomaterials offer cancer research the third dimension. Nature materials. 2010 Feb; 9(2): 90–3. doi:10.1038/nmat2619.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kankala R.K., Xu X.M., Liu C.G., Chen A.Z., Wang S.B. 3Dprinting of microfibrous porous scaffolds based on hybrid approaches for bone tissue engineering. Polymers (Basel). 2018; 10(7). doi: 10.3390/polym10070807.</mixed-citation><mixed-citation xml:lang="en">Kankala R.K., Xu X.M., Liu C.G., Chen A.Z., Wang S.B. 3Dprinting of microfibrous porous scaffolds based on hybrid approaches for bone tissue engineering. Polymers (Basel). 2018; 10(7). doi: 10.3390/polym10070807.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Farach-Carson M.C., Warren C.R., Harrington D.A., Carson D.D. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol. 2014 Feb; 34: 64–79. doi: 10.1016/j.matbio.2013.08.004.</mixed-citation><mixed-citation xml:lang="en">Farach-Carson M.C., Warren C.R., Harrington D.A., Carson D.D. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol. 2014 Feb; 34: 64–79. doi: 10.1016/j.matbio.2013.08.004.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Theocharis A.D., Skandalis S.S., Gialeli C., Karamanos N.K. Extracellular matrix structure. Adv Drug Deliv Rev. 2016 Feb; 97: 4–27. doi: 10.1016/j.addr.2015.11.001.</mixed-citation><mixed-citation xml:lang="en">Theocharis A.D., Skandalis S.S., Gialeli C., Karamanos N.K. Extracellular matrix structure. Adv Drug Deliv Rev. 2016 Feb; 97: 4–27. doi: 10.1016/j.addr.2015.11.001.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Grindel B.J., Martinez J.R., Pennington C.L., Muldoon M., Stave J., Chung L.W., Farach-Carson M.C. Matrilysin/matrix metalloproteinase- 7(MMP7) cleavage of perlecan/ HSPG2 creates a molecular switch to alter prostate cancer cell behavior. Matrix Biol. 2014; 36: 64–76. doi: 10.1016/j.matbio.2014.04.005.</mixed-citation><mixed-citation xml:lang="en">Grindel B.J., Martinez J.R., Pennington C.L., Muldoon M., Stave J., Chung L.W., Farach-Carson M.C. Matrilysin/matrix metalloproteinase- 7(MMP7) cleavage of perlecan/ HSPG2 creates a molecular switch to alter prostate cancer cell behavior. Matrix Biol. 2014; 36: 64–76. doi: 10.1016/j.matbio.2014.04.005.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sabeh F., Shimizu-Hirota R., Weiss S.J. Protease-dependent versusindependent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol. 2009 Apr; 185(1): 11–9. doi: 10.1083/jcb.200807195.</mixed-citation><mixed-citation xml:lang="en">Sabeh F., Shimizu-Hirota R., Weiss S.J. Protease-dependent versusindependent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol. 2009 Apr; 185(1): 11–9. doi: 10.1083/jcb.200807195.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shoval H., Karsch-Bluman A., Brill-Karniely Y., Stern T., Zamir G., Hubert A., Benny O. Tumor cells and their crosstalk with endothelial cells in 3D spheroids. Sci Rep. 2017 Sep 5; 7(1): 10428. doi: 10.1038/s41598-017-10699-y.</mixed-citation><mixed-citation xml:lang="en">Shoval H., Karsch-Bluman A., Brill-Karniely Y., Stern T., Zamir G., Hubert A., Benny O. Tumor cells and their crosstalk with endothelial cells in 3D spheroids. Sci Rep. 2017 Sep 5; 7(1): 10428. doi: 10.1038/s41598-017-10699-y.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Panzetta V., Musella I., Rapa I., Volante M., Netti P.A., Fusco S. Mechanical phenotyping of cells and extracellular matrix as grade and stage markers of lung tumor tissues. Acta Biomaterialia. 2017 Jul; 57: 334–41. doi: 10.1016/j.actbio.2017.05.002.</mixed-citation><mixed-citation xml:lang="en">Panzetta V., Musella I., Rapa I., Volante M., Netti P.A., Fusco S. Mechanical phenotyping of cells and extracellular matrix as grade and stage markers of lung tumor tissues. Acta Biomaterialia. 2017 Jul; 57: 334–41. doi: 10.1016/j.actbio.2017.05.002.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kim K., Dean D., Mikos A.G., Fisher J.P. Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on crosslinked poly(propylene fumarate) disks. Biomacromolecules. 2009; 10: 1810–7. doi: 10.1021/bm900240k.</mixed-citation><mixed-citation xml:lang="en">Kim K., Dean D., Mikos A.G., Fisher J.P. Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on crosslinked poly(propylene fumarate) disks. Biomacromolecules. 2009; 10: 1810–7. doi: 10.1021/bm900240k.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Melchels F.P., Feijen J., Grijpma D.W. A poly (D,L-lactide) resin for the preparation of tissue engineering scaffolds by stereolithography. Biomaterials. 2009 Aug; 30(23–24): 3801–9. doi: 10.1016/j.biomaterials.2009.03.055.</mixed-citation><mixed-citation xml:lang="en">Melchels F.P., Feijen J., Grijpma D.W. A poly (D,L-lactide) resin for the preparation of tissue engineering scaffolds by stereolithography. Biomaterials. 2009 Aug; 30(23–24): 3801–9. doi: 10.1016/j.biomaterials.2009.03.055.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Osmond M., Bernier S.M., Pantcheva M.B., Krebs M.D. Collagen and collagen‐chondroitin sulfate scaffolds with uniaxially aligned pores for the biomimetic, three dimensional culture of trabecular meshwork cells. Biotechnol Bioengin. 2017 Apr; 114(4): 915–23. doi: 10.1002/bit.26206.</mixed-citation><mixed-citation xml:lang="en">Osmond M., Bernier S.M., Pantcheva M.B., Krebs M.D. Collagen and collagen‐chondroitin sulfate scaffolds with uniaxially aligned pores for the biomimetic, three dimensional culture of trabecular meshwork cells. Biotechnol Bioengin. 2017 Apr; 114(4): 915–23. doi: 10.1002/bit.26206.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tiffany A.S., Gray D.L., Woods T.J., Subedi K, Harley B.A.C. The inclusion of zinc into mineralized collagen scaffolds for craniofacial bone repair applications. Acta Biomaterialia. 2019 Jul; 93: 86–96. doi: 10.1016/j.actbio.2019.05.031.</mixed-citation><mixed-citation xml:lang="en">Tiffany A.S., Gray D.L., Woods T.J., Subedi K, Harley B.A.C. The inclusion of zinc into mineralized collagen scaffolds for craniofacial bone repair applications. Acta Biomaterialia. 2019 Jul; 93: 86–96. doi: 10.1016/j.actbio.2019.05.031.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Prestwich G.D. Simplifying the extracellular matrix for 3‐D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem. 2007 Aug 15; 101(6): 1370–83. doi: 10.1002/jcb.21386.</mixed-citation><mixed-citation xml:lang="en">Prestwich G.D. Simplifying the extracellular matrix for 3‐D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem. 2007 Aug 15; 101(6): 1370–83. doi: 10.1002/jcb.21386.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lam N.T., Lam H., Sturdivant N.M., Balachandran K. Fabrication of a matrigel–collagen semi-interpenetrating scaffold for use in dynamic valve interstitial cell culture. Biomedical Materials. 2017 Jul 24; 12(4): 045013. doi: 10.1088/1748-605X/aa71be.</mixed-citation><mixed-citation xml:lang="en">Lam N.T., Lam H., Sturdivant N.M., Balachandran K. Fabrication of a matrigel–collagen semi-interpenetrating scaffold for use in dynamic valve interstitial cell culture. Biomedical Materials. 2017 Jul 24; 12(4): 045013. doi: 10.1088/1748-605X/aa71be.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Anguiano M., Castilla C., Maska M., Ederra C., Pelaez R., Morales X., Munoz-Arrieta G., Mujika M., Kozubek M., Munoz-Barrutia A., Rouzaut A., Arana S., Garcia-Aznar J.M., Ortiz-de-Solorzano C. Characterization of three-dimensional cancer cell migration in mixed collagen- Matrigel scaffolds using microfluidics and image analysis. PloS one. 2017 Feb 6; 12(2). doi: 10.1371/journal.pone.0171417.</mixed-citation><mixed-citation xml:lang="en">Anguiano M., Castilla C., Maska M., Ederra C., Pelaez R., Morales X., Munoz-Arrieta G., Mujika M., Kozubek M., Munoz-Barrutia A., Rouzaut A., Arana S., Garcia-Aznar J.M., Ortiz-de-Solorzano C. Characterization of three-dimensional cancer cell migration in mixed collagen- Matrigel scaffolds using microfluidics and image analysis. PloS one. 2017 Feb 6; 12(2). doi: 10.1371/journal.pone.0171417.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Maru Y., Tanaka N., Itami M., Hippo Y. Efficient use of patientderived organoids as a preclinical model for gynecologic tumors. Gynecol Oncol. 2019 Jul; 154(1): 189–98. doi: 10.1016/j.ygyno.2019.05.005.</mixed-citation><mixed-citation xml:lang="en">Maru Y., Tanaka N., Itami M., Hippo Y. Efficient use of patientderived organoids as a preclinical model for gynecologic tumors. Gynecol Oncol. 2019 Jul; 154(1): 189–98. doi: 10.1016/j.ygyno.2019.05.005.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Li P., Sakuma K., Tsuchiya S., Sun L., Hayamizu Y. Fibroin-like peptides self-assembling on two-dimensional materials as a molecular scaffold for potential biosensing. ACS Appl Mater Interfaces. 2019 Jun 12; 11(23): 20670–7. doi: 10.1021/acsami.9b04079.</mixed-citation><mixed-citation xml:lang="en">Li P., Sakuma K., Tsuchiya S., Sun L., Hayamizu Y. Fibroin-like peptides self-assembling on two-dimensional materials as a molecular scaffold for potential biosensing. ACS Appl Mater Interfaces. 2019 Jun 12; 11(23): 20670–7. doi: 10.1021/acsami.9b04079.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Кокорев О.В., Ходоренко В.Н., Аникеев С.Г., Дамбаев Г.Ц., Гюнтер В.Э. Особенности использования пористо-проницаемых инкубаторов из никелида титана в качестве носителей клеточных культур поджелудочной железы. Вестник новых медицинских технологий. 2014; (1): 47.</mixed-citation><mixed-citation xml:lang="en">Kokorev O.V., Khodorenko V.N., Anikeev S.G., Dambaev G.Ts., Gunter V.E. Features of the use of porous-permeable incubators made of titanium nickelide as carriers of pancreatic cell cultures. Bulletin of New Medical Technologies. 2014; (1): 47. (in Russian). doi: 10.12737/46813.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Кокорев О.В., Ходоренко В.Н., Дамбаев Г.Ц., Гюнтер В.Э. Функциональная характеристика тканевых эквивалентов различных тканей с использованием пористо-проницаемых инкубаторов из никелида титана. Acta Biomedica Scientifica. 2015; (2): 73–9</mixed-citation><mixed-citation xml:lang="en">Kokorev O.V., Khodorenko V.N., Dambaev G.Ts., Gunter V.E. Functional characterization of tissue equivalents of various tissues using porous-permeable titanium nickelide incubators. Acta Biomedica Scientifica. 2015; (2): 73–9. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Murphy C.M., Haugh M.G., O’Brien F.J. The effect of mean pore size on cell attachment, proliferation and migration in collagenglycosaminoglycan scaffolds for bone tissue engineering. Biomaterials. 2010 Jan; 31(3): 461–6. doi: 10.1016/j.biomaterials.2009.09.063.</mixed-citation><mixed-citation xml:lang="en">Murphy C.M., Haugh M.G., O’Brien F.J. The effect of mean pore size on cell attachment, proliferation and migration in collagenglycosaminoglycan scaffolds for bone tissue engineering. Biomaterials. 2010 Jan; 31(3): 461–6. doi: 10.1016/j.biomaterials.2009.09.063.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Carvalho M.R., Lima D., Reis R.L., Correlo V.M., Oliveira J.M. Evaluating biomaterial-and microfluidic-based 3D tumor models. Trends Biotechnol. 2015; 33(11): 667–78. doi: 10.1016/j.tibtech.2015.09.009.</mixed-citation><mixed-citation xml:lang="en">Carvalho M.R., Lima D., Reis R.L., Correlo V.M., Oliveira J.M. Evaluating biomaterial-and microfluidic-based 3D tumor models. Trends Biotechnol. 2015; 33(11): 667–78. doi: 10.1016/j.tibtech.2015.09.009.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Галимова Э.С., Галагудза М.М. Двухмерные и трехмерные модели культур клеток опухолей in vitro: преимущества и недостатки. Бюллетень сибирской медицины. 2018; 17(3): 188–96.</mixed-citation><mixed-citation xml:lang="en">Galimova E.S., Galagudza M.М. Two-dimensional and three-dimensional cell culture models in vitro: pros and cons. Bulletin of Siberian Medicine. 2018; 17(3): 188–96. (in Russian). doi: 10.20538/1682-0363-2018-3-188-196.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Liu G., Wang B., Li S., Jin Q., Dai Y. Human breast cancer decellularized scaffolds promote epithelial-to-mesenchymal transitions and stemness of breast cancer cells in vitro. J Cell Physiol. 2019; 234(6): 9447–56. doi: 10.1002/jcp.27630.</mixed-citation><mixed-citation xml:lang="en">Liu G., Wang B., Li S., Jin Q., Dai Y. Human breast cancer decellularized scaffolds promote epithelial-to-mesenchymal transitions and stemness of breast cancer cells in vitro. J Cell Physiol. 2019; 234(6): 9447–56. doi: 10.1002/jcp.27630.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz‐Neves S., Ribeiro N., Graca I., Jeronimo C., Sousa S.R., Monteiro F.J. Behavior of prostate cancer cells in a nanohydroxyapatite/ collagen bone scaffold. J Biomed Mater Res A. 2017; 105(7): 2035–46. doi: 10.1002/jbm.a.36070.</mixed-citation><mixed-citation xml:lang="en">Cruz‐Neves S., Ribeiro N., Graca I., Jeronimo C., Sousa S.R., Monteiro F.J. Behavior of prostate cancer cells in a nanohydroxyapatite/ collagen bone scaffold. J Biomed Mater Res A. 2017; 105(7): 2035–46. doi: 10.1002/jbm.a.36070.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Gock M., Kühn F., Mullins C.S., Krohn M., Prall F., Klar E., Linnebacher M. Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft Models. Biomed Res Int. 2016; 2016: 1715053. doi: 10.1155/2016/1715053.</mixed-citation><mixed-citation xml:lang="en">Gock M., Kühn F., Mullins C.S., Krohn M., Prall F., Klar E., Linnebacher M. Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft Models. Biomed Res Int. 2016; 2016: 1715053. doi: 10.1155/2016/1715053.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Moshe A., Izraely S., Sagi-Assif O., Prakash R., Telerman A., Meshel T., Carmichael T., Witz I.P. Cystatin C takes part in melanomamicroglia cross-talk: possible implications for brain metastasis. Clin Exp Metastasis. 2018; 35(5–6): 369–78. doi: 10.1007/s10585-018-9891-0.</mixed-citation><mixed-citation xml:lang="en">Moshe A., Izraely S., Sagi-Assif O., Prakash R., Telerman A., Meshel T., Carmichael T., Witz I.P. Cystatin C takes part in melanomamicroglia cross-talk: possible implications for brain metastasis. Clin Exp Metastasis. 2018; 35(5–6): 369–78. doi: 10.1007/s10585-018-9891-0.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Кит О.И., Колесников Е.Н., Максимов А.Ю., Протасова Т.П., Гончарова А.С., Лукбанова Е.А. Методы создания ортотопических моделей рака пищевода и их применение в доклинических исследованиях. Современные проблемы науки и образования. 2019; (2): 96.</mixed-citation><mixed-citation xml:lang="en">Kit O.I., Kolesnikov E.N., Maksimov A.Yu., Protasova T.P., Goncharova A.S., Lukbanova E.A. Methods for creating orthotopic models of esophageal cancer and their application in preclinical studies. Modern Problems of Science and Education. 2019; (2): 96. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Павлова А.А., Масчан М.А., Пономарев В.Б. Адоптивная иммунотерапия генетически модифицированными Т-лимфоцитами, экспрессирующими химерные антигенные рецепторы. Онкогематология. 2017; 12(1): 17–32.</mixed-citation><mixed-citation xml:lang="en">Pavlova A.А., Maschan M.А., Ponomarev V.B. Adoptitive immunotherapy with genetically engineered T-lymphocytes modified to express chimeric antigen receptors. Oncohematology. 2017; 12(1): 17–32. (in Russian). doi: 10.17650/1818-8346-2017-12-1-17-32.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Morishita S., Tsubaki A., Hotta K., Fu J.B., Fuji S. The benefit of exercise in patients who undergo allogeneic hematopoietic stem cell transplantation. J Int Soc Phys Rehabil Med. 2019; 2(1): 54–61. doi: 10.4103/jisprm.jisprm_2_19.</mixed-citation><mixed-citation xml:lang="en">Morishita S., Tsubaki A., Hotta K., Fu J.B., Fuji S. The benefit of exercise in patients who undergo allogeneic hematopoietic stem cell transplantation. J Int Soc Phys Rehabil Med. 2019; 2(1): 54–61. doi: 10.4103/jisprm.jisprm_2_19.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Melief C.J.M. Cancer: precision T-cell therapy targets tumours. Nature. 2017; 547(7662): 165–7. doi: 10.1038/nature23093.</mixed-citation><mixed-citation xml:lang="en">Melief C.J.M. Cancer: precision T-cell therapy targets tumours. Nature. 2017; 547(7662): 165–7. doi: 10.1038/nature23093.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Bonifant C.L., Jackson H.J., Brentjens R.J., Curran K.J. Toxicity and management in CAR T-cell therapy. Mol Ther Oncolytics. 2016; 3: 16011. doi: 10.1038/mto.2016.11.</mixed-citation><mixed-citation xml:lang="en">Bonifant C.L., Jackson H.J., Brentjens R.J., Curran K.J. Toxicity and management in CAR T-cell therapy. Mol Ther Oncolytics. 2016; 3: 16011. doi: 10.1038/mto.2016.11.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Rose F.R., Oreffo R.O. Bone tissue engineering: hope vs hype. Biochem Biophys Res Commun. 2002; 292(1): 1–7. doi: 10.1006/bbrc.2002.6519.</mixed-citation><mixed-citation xml:lang="en">Rose F.R., Oreffo R.O. Bone tissue engineering: hope vs hype. Biochem Biophys Res Commun. 2002; 292(1): 1–7. doi: 10.1006/bbrc.2002.6519.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Farshadi M., Johari B., Erfani Ezadyar E., Gholipourmalekabadi M., Azami M., Madanchi H., Haramshahi S.M.A., Yari A., Karimizade A., Nekouian R., Samadikuchaksaraei A. Nanocomposite scaffold seeded with mesenchymal stem cells for bone repair. Cell Biol Int. 2019 Feb 27. doi: 10.1002/cbin.11124.</mixed-citation><mixed-citation xml:lang="en">Farshadi M., Johari B., Erfani Ezadyar E., Gholipourmalekabadi M., Azami M., Madanchi H., Haramshahi S.M.A., Yari A., Karimizade A., Nekouian R., Samadikuchaksaraei A. Nanocomposite scaffold seeded with mesenchymal stem cells for bone repair. Cell Biol Int. 2019 Feb 27. doi: 10.1002/cbin.11124.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Епишев В.В., Петрова Л.Н., Аладин А.С., Смирнов В.А., Сулацкая Е.Ю., Эрлих В.В., Важенин А.В. Опыт применения индивидуальных титановых имплантатов для восстановления анатомической структуры носа. Вестник трансплантологии и искусственных органов. 2016; 18(3): 107–15.</mixed-citation><mixed-citation xml:lang="en">Epishev V.V., Petrova L.N., Aladin A.S., Smirnov V.A., Sulatskaya E.Yu., Erlikh V.V., Vazhenin A.V. Experience of using individual titan implants in nasal reconstruction surgery. Russian Journal of Transplantology and Artificial Organs. 2016; 18(3): 107–15. (in Russian). doi: 10.15825/1995-1191-2016-3-107-115.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">So E., Mandas V.H., Hlad L. Large osseous defect reconstruction using a custom three-dimensional printed titanium truss implant. J Foot Ankle Surg. 2018; 57(1): 196–204. doi: 10.1053/j.jfas.2017.07.019.</mixed-citation><mixed-citation xml:lang="en">So E., Mandas V.H., Hlad L. Large osseous defect reconstruction using a custom three-dimensional printed titanium truss implant. J Foot Ankle Surg. 2018; 57(1): 196–204. doi: 10.1053/j.jfas.2017.07.019.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
